Key result
Statewide health data tracking reveals statin use spans <50% of recommended days for ASCVD prevention.
Why the study?
The study was conducted to demonstrate whether a centrally managed health information exchange standardized to a common data model can facilitate the semantic data flow required to support a learning health system.
Observational (n=62,999)
Yes
Standardizing statewide health information exchange data to a common data model enables granular, longitudinal tracking of ASCVD risk and reveals significant gaps in guideline-directed statin therapy.
No takes yet. Share an insight, caveat, or question.
May indicate statin underuse in at-risk groups; extends common data models for real-world ASCVD surveillance.
Eisman et al. (2024) conducted an observational in Atherosclerotic cardiovascular disease (ASCVD) risk (n=62,999). Health information exchange standardized to a common data model (HIE-CDM) was evaluated on Longitudinal 10-year ASCVD risk and primary prevention practices. Standardizing a statewide health information exchange to a common data model enabled longitudinal ASCVD risk tracking for 62,999 individuals, showing statin use was <50% of recommended days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: